Option Care Health Reports Mixed Q1 2026 Results Amid Growth Concerns
Event summary
- Q1 2026 revenue up 1.3% YoY to $1,350.7M but GAAP net income down 3.0% to $45.3M.
- Adjusted EBITDA fell 6.3% YoY to $104.8M; adjusted EPS flat at $0.40.
- Company repurchased $17.5M of stock and expanded revolving credit facility from $400M to $850M.
- Full-year 2026 guidance revised: revenue now expected between $5.675B-$5.775B.
The big picture
Option Care Health's Q1 results reflect broader challenges in the home infusion services sector, where revenue growth has slowed amid increasing competition and regulatory pressures. The company's decision to expand its credit facility suggests a focus on financial flexibility as it navigates these headwinds. With over $5B in annual revenue, Option Care Health remains a key player, but its ability to sustain margins will be critical for long-term value creation.
What we're watching
- Revenue Growth
- Whether Option Care Health can re-accelerate revenue growth after a sluggish Q1.
- Cost Management
- The impact of declining adjusted EBITDA on profitability and operational efficiency.
- Debt Strategy
- How the expanded $850M revolving credit facility will be utilized for strategic initiatives.
Related topics